Analyst Ratings for Century Therapeutics (IPSC)
IPSC Rating Summary
IPSC Price Target Summary
- Highest: $8.00 (Mizuho)
- Lowest: $2.00 (Leerink)
- Average: $5.12
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$5.12 (+123.6%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
Avg. $ Target:
$5.12 (+123.6%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Mizuho | Salim Syed | New Coverage | Outperform (N/A) |
8.00 (N/A) |
2.26 (2.29) |
1.33% | Details |
| 2/25/2026 | TD Cowen | Phil Nadeau | New Coverage | Buy (N/A) |
N/A (N/A) |
2.13 (2.29) |
7.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
